Edward Neuwelt
OHSU Knight Cancer Institute
4
4
3
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+2 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Katherine E Warren, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Jeffrey Olson, MD
Emory University
Shared therapeutic areas:
Kathrin Milbury
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Katherine B Peters, MD, PhD
Duke University
Shared therapeutic areas:
Jan Drappatz, MD
Dana-Farber Cancer Institute
Shared therapeutic areas:
Jiayi Huang, M.D.
Washington University School of Medicine
Shared therapeutic areas:
Richard Wahl, MD
Johns Hopkins University
Shared therapeutic areas:
Thomas Gribbin, MD
St. Mary's Health Care
Shared therapeutic areas:
Sean Grimm, MD
Northwestern University
Shared therapeutic areas:
Steven Chmura, MD
University of Chicago
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors
Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases
MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
All 4 trials loaded